Your browser doesn't support javascript.
loading
A reference map of the human binary protein interactome.
Luck, Katja; Kim, Dae-Kyum; Lambourne, Luke; Spirohn, Kerstin; Begg, Bridget E; Bian, Wenting; Brignall, Ruth; Cafarelli, Tiziana; Campos-Laborie, Francisco J; Charloteaux, Benoit; Choi, Dongsic; Coté, Atina G; Daley, Meaghan; Deimling, Steven; Desbuleux, Alice; Dricot, Amélie; Gebbia, Marinella; Hardy, Madeleine F; Kishore, Nishka; Knapp, Jennifer J; Kovács, István A; Lemmens, Irma; Mee, Miles W; Mellor, Joseph C; Pollis, Carl; Pons, Carles; Richardson, Aaron D; Schlabach, Sadie; Teeking, Bridget; Yadav, Anupama; Babor, Mariana; Balcha, Dawit; Basha, Omer; Bowman-Colin, Christian; Chin, Suet-Feung; Choi, Soon Gang; Colabella, Claudia; Coppin, Georges; D'Amata, Cassandra; De Ridder, David; De Rouck, Steffi; Duran-Frigola, Miquel; Ennajdaoui, Hanane; Goebels, Florian; Goehring, Liana; Gopal, Anjali; Haddad, Ghazal; Hatchi, Elodie; Helmy, Mohamed; Jacob, Yves.
Affiliation
  • Luck K; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kim DK; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Lambourne L; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Spirohn K; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Begg BE; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
  • Bian W; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Brignall R; Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada.
  • Cafarelli T; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Campos-Laborie FJ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Charloteaux B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Choi D; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Coté AG; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Daley M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Deimling S; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Desbuleux A; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Dricot A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gebbia M; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hardy MF; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Kishore N; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Knapp JJ; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kovács IA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Lemmens I; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Mee MW; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Mellor JC; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Pollis C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Pons C; Cancer Research Center (CiC-IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.
  • Richardson AD; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Schlabach S; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Teeking B; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Yadav A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Babor M; The Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada.
  • Balcha D; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Basha O; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
  • Bowman-Colin C; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Chin SF; Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada.
  • Choi SG; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Colabella C; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Coppin G; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • D'Amata C; Department of Cell and Systems Biology, University of Toronto, Toronto, Ontario, Canada.
  • De Ridder D; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • De Rouck S; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Duran-Frigola M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ennajdaoui H; Molecular Biology of Diseases, Groupe Interdisciplinaire de Génomique Appliquée (GIGA) and Laboratory of Viral Interactomes, University of Liège, Liège, Belgium.
  • Goebels F; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Goehring L; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Gopal A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Haddad G; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hatchi E; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
  • Helmy M; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Jacob Y; Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada.
Nature ; 580(7803): 402-408, 2020 04.
Article de En | MEDLINE | ID: mdl-32296183
ABSTRACT
Global insights into cellular organization and genome function require comprehensive understanding of the interactome networks that mediate genotype-phenotype relationships1,2. Here we present a human 'all-by-all' reference interactome map of human binary protein interactions, or 'HuRI'. With approximately 53,000 protein-protein interactions, HuRI has approximately four times as many such interactions as there are high-quality curated interactions from small-scale studies. The integration of HuRI with genome3, transcriptome4 and proteome5 data enables cellular function to be studied within most physiological or pathological cellular contexts. We demonstrate the utility of HuRI in identifying the specific subcellular roles of protein-protein interactions. Inferred tissue-specific networks reveal general principles for the formation of cellular context-specific functions and elucidate potential molecular mechanisms that might underlie tissue-specific phenotypes of Mendelian diseases. HuRI is a systematic proteome-wide reference that links genomic variation to phenotypic outcomes.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéome Limites: Humans Langue: En Journal: Nature Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéome Limites: Humans Langue: En Journal: Nature Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
...